Sign in
CompletedNo phase

Electronic Quitline Referral With Enhanced Academic Detailing for the Promotion of Smoking Cessation

Key facts

Who runs it
OHSU Knight Cancer Institute
Where
Portland, United StatesSee the site
Trial code
Status
Completed
People taking part
9,133 people enrolled
Started
20 Jun 2023
Ended
22 Feb 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Enhanced Academic Detailing
  • Informational Intervention
Record updated
21 October 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 7 criteriaShow less

Other criteria

  • Study Clinic Inclusion Criteria:
  • In Oregon
  • On the OCHIN Epic EHR for >= 1 year
  • Willing to be randomized to the intervention or comparison condition
  • Willing to recruit a provider to serve as a clinic champion (to share monthly performance audit and feedback at all-staff meetings, determine desired content of booster sessions with clinic team members, and complete a survey at the completion of the intervention period) and a clinic manager to coordinate training and booster sessions; Study Patient Inclusion Criteria:
  • Adult patients (>= 18 years of age)
  • Identified as current tobacco users during >= 1 ambulatory and/or telehealth visit to one of the eligible study clinics over the 26-month study period

Where in United States

  • OHSU Knight Cancer InstitutePortland, United States

About the trial

What the trial wants to find out

This phase IV clinical trial determines the impact of implementing a Quitline electronic (e)Referral system with an enhanced academic detailing implementation strategy on Quitline reach, tobacco cessation assistance and self-reported quit rates among patients in community health centers. It also examines the cost-effectiveness of Quitline eReferrals both with and without enhanced academic detailing. If this implementation strategy is effective, this strategy could be used to increase tobacco cessation treatment through the collaboration between state Quitlines and community health centers that serve large numbers of socioeconomically disadvantaged patients who use tobacco.

The 2 groups in the trial

  • Arm I (Quitline eReferral)Existing treatment, for comparison

    Clinics are notified via email that the Quitline eReferral system is available with a link to an online publication that includes an overview of Quitline services, information on Quitline effectiveness, and a detailed eReferral workflow with corresponding EHR screenshots, including how to identify eligible patients, create an eReferral, and access Quitline follow-up data in the EHR. Clinics also gain access to technological assistance, as needed.

    Treatment: Informational Intervention

  • ARM II (Quitline eReferral plus enhanced AD)Treatment being tested

    Clinics receive standard online materials access to remote technological assistance as in Arm I. Clinics also receive group training of clinic staff prior to activation of the eReferral system and 12 months post-activation, follow-up booster sessions and monthly performance audit and feedback.

    Treatment: Enhanced Academic Detailing and Informational Intervention

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
CONNECT: COmpreheNsive TraiNing and Engagement in Cessation Treatment
Record updated
21 October 2026